| __timestamp | Blueprint Medicines Corporation | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 79838000 |
| Thursday, January 1, 2015 | 48588000 | 121816000 |
| Friday, January 1, 2016 | 81131000 | 117633000 |
| Sunday, January 1, 2017 | 144687000 | 117456000 |
| Monday, January 1, 2018 | 243621000 | 171984000 |
| Tuesday, January 1, 2019 | 331450000 | 257452000 |
| Wednesday, January 1, 2020 | 326860000 | 477643000 |
| Friday, January 1, 2021 | 601033000 | 540684000 |
| Saturday, January 1, 2022 | 477419000 | 651496000 |
| Sunday, January 1, 2023 | 427720000 | 666563000 |
| Monday, January 1, 2024 | 341433000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Blueprint Medicines Corporation and PTC Therapeutics, Inc. have demonstrated their dedication to advancing medical science through substantial R&D investments.
From 2014 to 2023, Blueprint Medicines increased its R&D spending by over 1,200%, peaking in 2021. Meanwhile, PTC Therapeutics consistently outpaced Blueprint, with a 735% increase, culminating in 2023 with a 56% higher expenditure than its rival. This trend highlights PTC's aggressive pursuit of innovation, particularly in recent years.
Both companies have shown a strong upward trajectory in R&D spending, reflecting their strategic focus on developing groundbreaking therapies. As the biotech landscape evolves, these investments are crucial for maintaining a competitive edge and delivering life-changing treatments.
AbbVie Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Merck & Co., Inc. vs PTC Therapeutics, Inc.
Analyzing R&D Budgets: AstraZeneca PLC vs PTC Therapeutics, Inc.
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.
Research and Development Investment: Blueprint Medicines Corporation vs ADMA Biologics, Inc.
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Veracyte, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and PTC Therapeutics, Inc.
Comparing Innovation Spending: Axsome Therapeutics, Inc. and PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs PTC Therapeutics, Inc.
R&D Insights: How PTC Therapeutics, Inc. and MannKind Corporation Allocate Funds
Analyzing R&D Budgets: PTC Therapeutics, Inc. vs Wave Life Sciences Ltd.
Research and Development Investment: PTC Therapeutics, Inc. vs MiMedx Group, Inc.